Latest Platform Technology News

Page 1 of 5
Euroz Hartleys Group delivered a sharp FY26 earnings recovery as revenue rose 43.6% and net profit increased 62.4%, while its $145 million sale of Capital Markets to BMO moved towards completion. The transaction will leave the ASX-listed group focused on Private Wealth, with a strategic question hanging over how much earnings power survives the separation.
Claire Turing
Claire Turing
27 Oct 2026
Mount Ridley has lodged a second provisional patent application for an adapted Selectro chemistry targeting industrial metal feedstocks, following first-pass bauxite recoveries of 92% aluminium and 97% iron. Gallium results are still pending, and the process has not yet been optimised for bauxite.
Victor Sage
Victor Sage
19 Oct 2026
Clinuvel Pharmaceuticals marked its tenth consecutive profit with stable revenues and rising cash reserves, while accelerating U.S. expansion including a Nasdaq uplisting and potential ASX delisting.
Victor Sage
Victor Sage
27 Aug 2026
Netwealth Group posted record FY26 revenue of $391 million, up 21%, with adjusted net profit rising 16.2% to $135.4 million after excluding $105 million in First Guardian compensation. The company declared a fully franked 21-cent final dividend, maintaining a 9.1% increase in total dividends.
Claire Turing
Claire Turing
26 Aug 2026
Imricor Medical Systems has officially launched its US commercial operations, securing Rady Children’s Hospital–San Diego as the first customer for its NorthStar iMR mapping system, following key FDA clearances including pediatric approvals.
Ada Torres
Ada Torres
27 July 2026
Immuron Limited reported a 6% increase in FY26 sales to AUD 7.7 million, driven by strong gains in Canada and the US despite mixed Australian performance. Marketing initiatives and retail expansion underpin growth.
Ada Torres
Ada Torres
16 July 2026
Chimeric Therapeutics reports encouraging interim data from its Phase 1/2 trial of CHM CDH17 CAR-T therapy, with tumour shrinkage up to 40% and stable disease maintained for months at the highest dose level.
Ada Torres
Ada Torres
16 July 2026
Recce Pharmaceuticals has expanded its intellectual property footprint with a key patent granted in Vietnam for its RECCE® anti-infective drugs, reinforcing its presence in a critical Southeast Asian market grappling with high antibiotic resistance.
Victor Sage
Victor Sage
14 July 2026
ION Video Limited (ASX: IOV) reported its first-ever positive operating cash flow of $179,847 for the June quarter, eliminated $2.65 million of debt through Convertible Note conversion, and expanded its patent portfolio to five families while advancing its Virtual Video platform technology.
Sophie Babbage
Sophie Babbage
7 July 2026
Netwealth has broadened its partnership with Morgan Stanley Wealth Management Australia by providing a new domestic platform for ASX equities and investments, underpinning robust FY26 fund inflows and an optimistic FY27 outlook.
Claire Turing
Claire Turing
7 July 2026
Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.
Ada Torres
Ada Torres
29 June 2026
Temas Resources' re-assay program at the Hervieux West deposit validates extensive high-grade titanium-vanadium mineralisation and reveals significant gallium, scandium, and chromium credits, accelerating resource development at the La Blache Project.
Maxwell Dee
Maxwell Dee
29 June 2026

Browse the archive

Full archive